Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference1x1 Investor Meetings: Friday, September 6, 2024Location: New York, NY

Baird 2024 Global Healthcare Conference Fireside Chat: Wednesday, September 11, 2024, at 7:55am ETLocation: New York, NY

Chardan’s 8th Annual Genetic Medicines Conference Fireside Chat: Monday, September 30, 2024, at 4:30pm ETLocation: New York, NY

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com

Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Vor Biopharma Charts.
Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Vor Biopharma Charts.